than when the vaccine alone is administered. [16] Rapid achievement of protective levels of antibody to hepatitis B virus may be desirable in certain clinical
Post-booster seroprotection or vaccine response rates for all H exyon® antigens were numerically similar in groups A and B (Table 3) [6]. The proportion of participants with an antibody titer level of ≥ 8 1/dil for anti- MenA, anti-MenC, anti-MenW,...
A: Phase contrast and GFP expression under a fluorescent microscope after 48 h in 293T cells; B: Protein mRNA and hepatocyte progenitor kinase-like kinase (HGK) levels after HepG2 cells were treated with different vectors detected by real-time reverse transcriptase polymerase chain reaction and ...